Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Hypereosinophilia With Organ Damage Secondary to Dupilumab Therapy: A Case Report and Literature Review. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3389/fimmu.2024.1361005
10.3389/fimmu.2024.1361005 · External reference
10.1016/j.abd.2020.10.016
10.1016/j.abd.2020.10.016 · External reference
10.5826/dpc.1104a146
10.5826/dpc.1104a146 · External reference
10.18176/jiaci.0906
10.18176/jiaci.0906 · External reference
10.1016/j.jaad.2020.08.051
10.1016/j.jaad.2020.08.051 · External reference
10.7573/dic.2020-2-3
10.7573/dic.2020-2-3 · External reference
10.1111/jdv.17981
10.1111/jdv.17981 · External reference
10.1016/j.jaip.2022.05.019
10.1016/j.jaip.2022.05.019 · External reference
10.1016/j.anai.2023.11.009
10.1016/j.anai.2023.11.009 · External reference
10.1007/s40257-025-00952-w
10.1007/s40257-025-00952-w · External reference
10.7573/dic.2024-3-5
10.7573/dic.2024-3-5 · External reference
10.1183/23120541.00048-2024
10.1183/23120541.00048-2024 · External reference
Eosinophilic Complications During Dupilumab Therapy for Type 2 Diseases: a Systematic Review
2025 · External reference
10.2147/jaa.s588165
10.2147/jaa.s588165 · External reference
10.7759/cureus.77797
10.7759/cureus.77797 · External reference
10.1111/cea.12878
10.1111/cea.12878 · External reference
10.1038/nrd4624
10.1038/nrd4624 · External reference
10.1016/j.jaci.2022.02.016
10.1016/j.jaci.2022.02.016 · External reference
10.1111/all.15844
10.1111/all.15844 · External reference
10.1111/cea.13954
10.1111/cea.13954 · External reference
10.1161/jaha.123.031454
10.1161/jaha.123.031454 · External reference
10.1186/s12968-023-00979-0
10.1186/s12968-023-00979-0 · External reference
10.14740/jmc5168
10.14740/jmc5168 · External reference
10.1111/ddg.15229
10.1111/ddg.15229 · External reference
10.4193/rhin23.357
10.4193/rhin23.357 · External reference
10.1080/07853890.2024.2311843
10.1080/07853890.2024.2311843 · External reference
Safety and Effectiveness of Dupilumab in the real-world Treatment of Atopic Dermatitis in Japan: 1-Year Interim Analysis from a Post-marketing Surveillance
10.1002/cia2.12303 · 2023 · External reference
10.3390/jcm15041525
10.3390/jcm15041525 · External reference
10.1016/j.jaci.2016.05.041
10.1016/j.jaci.2016.05.041 · External reference
